Akaza Research and Conecta Join Forces for OpenClinica in Italy
OpenClinica, an open source EDC system, to hit the Italian market thanks to a new partnership.
Cambridge, MA-June 12th, 2008-Conecta, an Italian open source consulting company, and Akaza Research, developers of OpenClinica, the leading open source Electronic Data Capture (EDC) software, jointly announce a development partnership aimed at bringing OpenClinica and OpenClinica Enterprise to the Italian clinical research market.
"OpenClinica is the most advanced open source EDC system in the market today", said Carlo Daffara, research director at Conecta. "After extensive evaluation, we found the tool to be flexible, complete, and well developed according to best practices in the clinical research software market. The flexibility of open source and the validated approach help in bringing EDC to new markets that have been until now, locked into proprietary and inflexible solutions."
”We are pleased to be working with Conecta,” said Benjamin Baumann, director of business development at Akaza Research. “This partnership will further strengthen OpenClinica’s presence across Europe, allowing more researchers to benefit from a professionally supported open source solution.”
OpenClinica is already in trial use at the Disability Italian Network and the Tuscany Region, in a specialized study based on the WHO ICF protocol, and is being implemented for the Regional Health Care Authority of the Friuli-Venezia Giulia region. An early outcome is the development of an Italian localization of OpenClinica that is expected to be included in the next production release of the product. In addition, the groups will share code and best practices for the dynamic forms and complex validation functionalities.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
